Diagnostic predictive value of the Bladder EpiCheck test in the follow‐up of patients with non–muscle‐invasive bladder cancer

Author:

Trenti Emanuela1ORCID,D'Elia Carolina2,Mian Christine2,Schwienbacher Christine2,Hanspeter Esther2,Pycha Alexander3,Kafka Mona4,Degener Stephan5,Danuser Hansjörg3,Roth Stephan5,Pycha Armin16

Affiliation:

1. Department of Urology Central Hospital of Bolzano Bolzano Italy

2. Department of Pathology Central Hospital of Bolzano Bolzano Italy

3. Department of Urology Lucerne Canton Hospital Lucerne Switzerland

4. Department of Urology Medical University of Innsbruck Innsbruck Austria

5. Department of Urology Helios‐Klinikum Wuppertal, Witten Herdecke University Wuppertal Germany

6. Medical School Sigmund Freud Private University Vienna Austria

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference21 articles.

1. FerlayJ SoerjomataramI ErvickM et al eds.GLOBOCAN 2012: Estimated Cancer Incidence Mortality and Prevalence Worldwide in 2012. Version 1.0.International Agency for Research on Cancer (IARC) CancerBase No. 11. Available at:https://gco.iarc.fr/today/fact-sheets-cancers.

2. Economic aspects of bladder cancer: what are the benefits and costs?

3. CAN URINE BOUND DIAGNOSTIC TESTS REPLACE CYSTOSCOPY IN THE MANAGEMENT OF BLADDER CANCER?

4. Comparison of the BTA statTM Test with Voided Urine Cytology and Bladder Wash Cytology in the Diagnosis and Monitoring of Bladder Cancer

5. Urine Markers for Bladder Cancer Surveillance: A Systematic Review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3